The Defense Threat Reduction Agency (DTRA) is identified as a major source of funding for biopharmaceutical companies. The agency's mission is to safeguard the U.S. against weapons of mass destruction, but it is characterized here as a vehicle for awarding massive, multi-billion dollar government contracts.
